Even though Denmark's, Austria's and Israel's vaccine production collaboration is still just an idea on the drawing board, the countries have already been in contact with multiple companies, according to Danish newspaper Børsen on the basis of an interview with Israeli Ambassador to Denmark Benny Dagan.
If these countries enter into a collaboration on future vaccine production, manufacturers like Teva, led by Danish national Kåre Schultz, will play a crucial role, says Dagan, according to Børsen:
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.